| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Cruzipain | 6 | 0 | 0 | 6 |
| IDH1 | 12 | 0 | 0 | 12 |
| DNA polymerase iota isoform a (long) | 9 | 0 | 0 | 9 |
| geminin | 32 | 0 | 0 | 32 |
| Sex hormone-binding globulin | 0 | 1 | 12 | 13 |
| acetylcholinesterase | 13 | 0 | 0 | 13 |
| pregnane X receptor | 10 | 0 | 0 | 10 |
| SMAD family member 2 | 10 | 0 | 0 | 10 |
| SMAD family member 3 | 10 | 0 | 0 | 10 |
| TDP1 protein | 36 | 0 | 0 | 36 |
| GLI family zinc finger 3 | 26 | 0 | 0 | 26 |
| Microtubule-associated protein tau | 9 | 0 | 0 | 9 |
| AR protein | 43 | 0 | 0 | 43 |
| progesterone receptor | 31 | 0 | 0 | 31 |
| glucocorticoid receptor [Homo sapiens] | 40 | 0 | 0 | 40 |
| retinoic acid nuclear receptor alpha variant 1 | 29 | 0 | 0 | 29 |
| retinoid X nuclear receptor alpha | 28 | 0 | 0 | 28 |
| estrogen-related nuclear receptor alpha | 31 | 0 | 0 | 31 |
| farnesoid X nuclear receptor | 18 | 0 | 0 | 18 |
| pregnane X nuclear receptor | 25 | 0 | 0 | 25 |
| estrogen nuclear receptor alpha | 44 | 0 | 0 | 44 |
| G | 14 | 0 | 0 | 14 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 21 | 0 | 0 | 21 |
| arylsulfatase A | 11 | 0 | 0 | 11 |
| euchromatic histone-lysine N-methyltransferase 2 | 31 | 0 | 0 | 31 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 27 | 0 | 0 | 27 |
| activating transcription factor 6 | 9 | 0 | 0 | 9 |
| nuclear receptor subfamily 1, group I, member 2 | 8 | 0 | 0 | 8 |
| chromobox protein homolog 1 | 24 | 0 | 0 | 24 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 28 | 0 | 0 | 28 |
| survival motor neuron protein isoform d | 15 | 0 | 0 | 15 |
| histone acetyltransferase KAT2A isoform 1 | 10 | 0 | 0 | 10 |
| lamin isoform A-delta10 | 21 | 0 | 0 | 21 |
| Voltage-dependent calcium channel gamma-2 subunit | 17 | 0 | 0 | 17 |
| Interferon beta | 20 | 0 | 0 | 20 |
| HLA class I histocompatibility antigen, B alpha chain | 14 | 0 | 0 | 14 |
| Glucocorticoid receptor | 1 | 13 | 5 | 27 |
| Glycine receptor subunit alpha-1 | 0 | 10 | 0 | 10 |
| Corticosteroid-binding globulin | 0 | 12 | 0 | 12 |
| Adenosine receptor A3 | 0 | 14 | 1 | 15 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Androgen receptor | 0 | 15 | 1 | 17 |
| Alpha-1B adrenergic receptor | 0 | 15 | 1 | 16 |
| Glutamate receptor 2 | 17 | 0 | 0 | 17 |
| Glycine receptor subunit beta | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-2 | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-3 | 0 | 10 | 0 | 10 |
| Mitogen-activated protein kinase 3 | 0 | 1 | 2 | 3 |
| Alpha-1A adrenergic receptor | 0 | 15 | 1 | 16 |
| Sodium-dependent dopamine transporter | 0 | 10 | 0 | 10 |
| TAR DNA-binding protein 43 | 10 | 0 | 0 | 10 |
| Inositol hexakisphosphate kinase 1 | 14 | 0 | 0 | 14 |
| cytochrome P450 2C9, partial | 14 | 0 | 0 | 14 |
| ATP-dependent phosphofructokinase | 15 | 0 | 0 | 15 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 11 | 0 | 0 | 11 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7 | 0 | 0 | 7 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 10 | 0 | 0 | 10 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| thioredoxin reductase | 15 | 0 | 0 | 15 |
| GLS protein | 12 | 0 | 0 | 12 |
| Thrombopoietin | 5 | 0 | 0 | 5 |
| cytochrome P450 2D6 isoform 1 | 6 | 0 | 0 | 6 |
| cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
| ras-related protein Rab-9A | 6 | 0 | 0 | 6 |
| lethal factor (plasmid) | 6 | 0 | 0 | 6 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 13 | 0 | 1 | 14 |
| ATAD5 protein, partial | 11 | 0 | 0 | 11 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| RAR-related orphan receptor gamma | 32 | 0 | 0 | 32 |
| Smad3 | 9 | 0 | 0 | 9 |
| aldehyde dehydrogenase 1 family, member A1 | 14 | 0 | 0 | 14 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| nuclear receptor subfamily 1, group I, member 3 | 18 | 0 | 0 | 18 |
| EWS/FLI fusion protein | 10 | 0 | 0 | 10 |
| peroxisome proliferator activated receptor gamma | 23 | 0 | 0 | 23 |
| aryl hydrocarbon receptor | 14 | 0 | 0 | 14 |
| thyroid hormone receptor beta isoform 2 | 30 | 0 | 0 | 30 |
| peripheral myelin protein 22 | 15 | 0 | 0 | 15 |
| cytochrome P450 3A4 isoform 1 | 12 | 0 | 0 | 12 |
| Gamma-aminobutyric acid receptor subunit pi | 12 | 2 | 1 | 15 |
| ATP-binding cassette sub-family C member 3 | 0 | 24 | 0 | 24 |
| Multidrug resistance-associated protein 4 | 0 | 25 | 0 | 26 |
| Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 12 | 0 | 3 | 0 | 5 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 6 | 0 | 6 |
| Bile salt export pump | 0 | 36 | 0 | 36 |
| Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 6 |
| Carbonic anhydrase 2 | 0 | 5 | 0 | 8 |
| Myoglobin | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
| Cytochrome P450 1A2 | 0 | 3 | 0 | 4 |
| Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 6 |
| Carbonic anhydrase 3 | 0 | 3 | 0 | 4 |
| Cytochrome P450 3A4 | 0 | 12 | 1 | 15 |
| Cytochrome P450 2D6 | 0 | 5 | 0 | 5 |
| Cytochrome P450 2C9 | 0 | 10 | 0 | 10 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 12 | 2 | 1 | 15 |
| Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 12 | 2 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 12 | 2 | 1 | 15 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 12 | 2 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 12 | 2 | 1 | 15 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 4 | 0 | 4 | 0 | 6 |
| Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 7 |
| Carbonic anhydrase 6 | 0 | 3 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 12 | 2 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 12 | 2 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 12 | 2 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 12 | 2 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 12 | 2 | 1 | 15 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 0 | 6 |
| Prostaglandin G/H synthase 2 | 0 | 5 | 1 | 8 |
| Carbonic anhydrase 7 | 0 | 3 | 0 | 5 |
| Nuclear receptor ROR-gamma | 10 | 0 | 0 | 10 |
| Cytochrome P450 2J2 | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 12 | 2 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 12 | 2 | 1 | 15 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 12 | 2 | 1 | 15 |
| Carbonic anhydrase 9 | 0 | 4 | 0 | 6 |
| GABA theta subunit | 12 | 2 | 1 | 15 |
| Canalicular multispecific organic anion transporter 1 | 0 | 23 | 0 | 23 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 3 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit epsilon | 12 | 2 | 1 | 15 |
| Carbonic anhydrase 14 | 0 | 3 | 0 | 5 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 5 |
| toxin B | 0 | 0 | 0 | 1 |
| Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
| Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 1 | 3 | 4 |
| Tyrosine-protein kinase Fyn | 0 | 4 | 3 | 7 |
| Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
| Mineralocorticoid receptor | 1 | 10 | 6 | 19 |
| Mineralocorticoid receptor | 0 | 4 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 5 |
| Guanine nucleotide-binding protein G | 6 | 0 | 0 | 6 |
| interleukin 8 | 6 | 0 | 0 | 6 |
| estrogen receptor 2 (ER beta) | 17 | 0 | 0 | 17 |
| Bloom syndrome protein isoform 1 | 12 | 0 | 0 | 12 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
| Cellular tumor antigen p53 | 23 | 0 | 0 | 23 |
| Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 6 | 2 | 8 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 1 | 4 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 2 | 0 | 2 |
| Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
| Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
| Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain A, 2-oxoglutarate Oxygenase | 9 | 0 | 0 | 9 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 11 | 0 | 0 | 11 |
| glucocerebrosidase | 5 | 0 | 0 | 5 |
| alpha-galactosidase | 4 | 0 | 0 | 4 |
| lysosomal alpha-glucosidase preproprotein | 5 | 0 | 0 | 5 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| huntingtin isoform 2 | 4 | 0 | 0 | 4 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 9 | 0 | 10 |
| Prothrombin | 0 | 2 | 0 | 2 |
| Coagulation factor X | 0 | 1 | 0 | 1 |
| Plasminogen | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
| Tissue-type plasminogen activator | 0 | 2 | 0 | 2 |
| Cationic trypsin | 0 | 1 | 0 | 1 |
| Coagulation factor XI | 0 | 1 | 0 | 1 |
| Plasma kallikrein | 0 | 2 | 0 | 3 |
| Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Sodium/hydrogen exchanger 1 | 0 | 2 | 0 | 2 |
| Sodium/hydrogen exchanger 3 | 0 | 2 | 0 | 2 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Amiloride-sensitive sodium channel subunit alpha | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
| Sodium/hydrogen exchanger 2 | 0 | 2 | 0 | 2 |
| Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 10 | 0 | 10 |
| Sodium channel protein type 5 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium/hydrogen exchanger 5 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
| Solute carrier family 22 member 2 | 0 | 5 | 0 | 6 |
| Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
| Sodium/hydrogen exchanger | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 6 | 0 | 0 | 6 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 22 | 0 | 0 | 22 |
| cytochrome P450 2D6 | 10 | 0 | 0 | 10 |
| NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
| NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 12 | 0 | 0 | 12 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
| Potassium channel subfamily K member 2 | 0 | 1 | 2 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 15 | 1 | 18 |
| Alpha-2A adrenergic receptor | 0 | 11 | 3 | 15 |
| Alpha-2C adrenergic receptor | 0 | 3 | 2 | 6 |
| Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| Alpha-2C adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2A adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-1D adrenergic receptor | 0 | 5 | 1 | 7 |
| Alpha-1A adrenergic receptor | 0 | 2 | 2 | 5 |
| Alpha-1B adrenergic receptor | 0 | 1 | 1 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 8 | 1 | 9 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 5 |
| Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
| nonstructural protein 1 | 5 | 0 | 0 | 5 |
| peroxisome proliferator-activated receptor delta | 21 | 0 | 0 | 21 |
| Histone H2A.x | 9 | 0 | 0 | 9 |
| Caspase-7 | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 isoform 1 | 10 | 0 | 0 | 10 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 8 | 0 | 0 | 8 |
| caspase-3 | 4 | 0 | 0 | 4 |
| importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
| mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 3 | 0 | 0 | 3 |
| GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
| neuropeptide S receptor isoform A | 5 | 0 | 0 | 5 |
| Beta-glucuronidase | 0 | 3 | 0 | 3 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 6 | 0 | 9 |
| Gastrin/cholecystokinin type B receptor | 0 | 0 | 0 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 2 | 0 | 2 |
| Alpha-synuclein | 5 | 1 | 0 | 6 |
| Chain A, retinol dehydratase | 0 | 1 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 14 | 0 | 0 | 14 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 5 | 0 | 5 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 4 | 4 |
| DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
| Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 2 | 2 | 4 |
| Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Type-1B angiotensin II receptor | 0 | 3 | 0 | 3 |
| Type-1 angiotensin II receptor | 0 | 7 | 3 | 12 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 4 | 0 | 4 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| phosphopantetheinyl transferase | 10 | 0 | 0 | 10 |
| NFKB1 protein, partial | 4 | 0 | 0 | 4 |
| flap endonuclease 1 | 6 | 0 | 0 | 6 |
| muscarinic acetylcholine receptor M1 | 7 | 0 | 0 | 7 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 10 | 0 | 10 |
| Muscarinic acetylcholine receptor M2 | 0 | 7 | 2 | 13 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 8 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 6 |
| Muscarinic acetylcholine receptor M3 | 0 | 3 | 1 | 6 |
| Muscarinic acetylcholine receptor M4 | 0 | 3 | 1 | 6 |
| Muscarinic acetylcholine receptor M5 | 0 | 3 | 1 | 6 |
| Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 8 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 1 | 7 |
| Muscarinic acetylcholine receptor M1 | 0 | 5 | 2 | 11 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 5 | 2 | 10 |
| 5-hydroxytryptamine receptor 2C | 0 | 10 | 1 | 11 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 4 | 0 | 1 | 6 |
| Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 2 | 1 | 3 |
| Luciferase | 7 | 0 | 0 | 7 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
| Thromboxane A2 receptor | 0 | 0 | 0 | 1 |
| Endothelin-1 receptor | 0 | 4 | 1 | 6 |
| Sodium/bile acid cotransporter | 0 | 5 | 0 | 5 |
| Multidrug and toxin extrusion protein 1 | 0 | 6 | 0 | 6 |
| Leukotriene B4 receptor 2 | 0 | 0 | 2 | 3 |
| Chain A, Beta-lactamase | 11 | 0 | 0 | 11 |
| glp-1 receptor, partial | 8 | 0 | 0 | 8 |
| Fumarate hydratase | 7 | 0 | 0 | 7 |
| PPM1D protein | 4 | 0 | 0 | 4 |
| polyprotein | 7 | 0 | 0 | 7 |
| 67.9K protein | 11 | 0 | 0 | 11 |
| Parkin | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 9 | 0 | 0 | 9 |
| urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
| plasminogen precursor | 4 | 0 | 0 | 4 |
| urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
| Integrin beta-3 | 3 | 1 | 0 | 4 |
| Integrin alpha-IIb | 3 | 0 | 0 | 3 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 5 | 0 | 5 |
| D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
| Histone-lysine N-methyltransferase EHMT2 | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 11 | 0 | 0 | 11 |
| Ataxin-2 | 15 | 0 | 0 | 15 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 2 |
| Multidrug resistance-associated protein 6 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 1 | 0 | 3 |
| USP1 protein, partial | 14 | 0 | 0 | 14 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 4 | 0 | 0 | 4 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 3 | 0 | 0 | 3 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 5 | 2 | 7 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 8 | 0 | 8 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 6 | 1 | 7 |
| Alpha-2B adrenergic receptor | 0 | 8 | 1 | 10 |
| 5-hydroxytryptamine receptor 1A | 0 | 7 | 1 | 9 |
| Sodium-dependent noradrenaline transporter | 0 | 8 | 0 | 8 |
| Thromboxane-A synthase | 0 | 5 | 0 | 5 |
| Type-1 angiotensin II receptor | 0 | 2 | 0 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| 10 kDa chaperonin | 0 | 2 | 0 | 2 |
| Vpr | 3 | 0 | 0 | 3 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
| M-phase phosphoprotein 8 | 10 | 0 | 0 | 10 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 2 | 1 | 3 |
| EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 1 | 3 |
| Angiotensin-converting enzyme | 0 | 4 | 0 | 5 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 1 | 1 |
| Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
| Succinyl-diaminopimelate desuccinylase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 1 | 3 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase TEM | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 4 | 1 | 5 |
| Beta-lactamase | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
| Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| relaxin receptor 2 isoform 1 | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 3 | 3 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 2 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 8 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 1 | 0 | 1 | 1 | 2 |
| Relaxin receptor 1 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| GALC protein | 6 | 0 | 0 | 6 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 11 | 0 | 0 | 11 |
| heat shock protein beta-1 | 12 | 0 | 0 | 12 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 3 | 0 | 4 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 2 | 0 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 3 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 8 | 0 | 8 |
| endonuclease IV | 5 | 0 | 0 | 5 |
| atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 1 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 8 | 0 | 0 | 8 |
| exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 11 | 0 | 0 | 11 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Steryl-sulfatase | 0 | 0 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 5 | 0 | 6 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 6 | 0 | 7 |
| Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
| thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 9 | 0 | 0 | 9 |
| Progesterone receptor | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 10 | 4 | 17 |
| Glucocorticoid receptor | 0 | 3 | 2 | 6 |
| Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
| Androgen receptor | 1 | 9 | 6 | 18 |
| Androgen receptor | 0 | 1 | 1 | 2 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
| ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
| Estrogen receptor | 1 | 9 | 4 | 15 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Estrogen receptor beta | 1 | 8 | 4 | 13 |
| Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
| Cytochrome P450 11B1, mitochondrial | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
| Cytochrome P450 11B2, mitochondrial | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 1 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Bone morphogenetic protein receptor type-1B | 0 | 0 | 2 | 2 |
| Cell division cycle 7-related protein kinase | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase PLK4 | 0 | 0 | 2 | 2 |
| ATP-dependent RNA helicase DDX3X | 0 | 0 | 2 | 2 |
| Pyridoxal kinase | 0 | 0 | 2 | 2 |
| Citron Rho-interacting kinase | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 2 | 2 |
| Aurora kinase A | 0 | 0 | 2 | 2 |
| Cyclin-G-associated kinase | 0 | 0 | 2 | 2 |
| Ephrin type-B receptor 6 | 0 | 0 | 2 | 2 |
| Peroxisomal acyl-coenzyme A oxidase 3 | 0 | 0 | 2 | 2 |
| Receptor-interacting serine/threonine-protein kinase 2 | 0 | 0 | 2 | 2 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | 0 | 0 | 2 | 2 |
| Dynamin-like 120 kDa protein, mitochondrial | 0 | 0 | 2 | 2 |
| Eukaryotic translation initiation factor 5B | 0 | 0 | 2 | 2 |
| Rho-associated protein kinase 2 | 0 | 1 | 3 | 4 |
| Serine/threonine-protein kinase ULK1 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | 0 | 0 | 2 | 2 |
| Ribosomal protein S6 kinase alpha-5 | 0 | 1 | 2 | 3 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | 0 | 0 | 2 | 2 |
| Ribosomal protein S6 kinase alpha-4 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase 16 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase 10 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase D3 | 0 | 2 | 2 | 5 |
| Structural maintenance of chromosomes protein 2 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase 6 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase LATS1 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase PAK 4 | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 2 | 3 |
| High affinity nerve growth factor receptor | 0 | 0 | 2 | 2 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | 0 | 0 | 1 | 1 |
| ADP/ATP translocase 2 | 0 | 0 | 2 | 2 |
| Protein kinase C beta type | 0 | 2 | 2 | 5 |
| Insulin receptor | 0 | 0 | 2 | 2 |
| Cyclin-dependent kinase 1 | 0 | 0 | 2 | 2 |
| Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase Fes/Fps | 0 | 0 | 2 | 2 |
| Adenine phosphoribosyltransferase | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase Yes | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase Lyn | 0 | 0 | 2 | 2 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 0 | 2 | 2 |
| Insulin-like growth factor 1 receptor | 0 | 0 | 2 | 2 |
| Signal recognition particle receptor subunit alpha | 0 | 0 | 2 | 2 |
| Cytochrome c1, heme protein, mitochondrial | 0 | 0 | 2 | 2 |
| Hepatocyte growth factor receptor | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase HCK | 0 | 0 | 2 | 2 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase Fgr | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase A-Raf | 0 | 0 | 2 | 2 |
| Glycogen phosphorylase, brain form | 0 | 0 | 2 | 2 |
| Breakpoint cluster region protein | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase pim-1 | 0 | 0 | 2 | 2 |
| Fibroblast growth factor receptor 1 | 0 | 1 | 2 | 3 |
| DNA topoisomerase 2-alpha | 0 | 0 | 2 | 2 |
| Cyclin-dependent kinase 4 | 0 | 0 | 2 | 2 |
| ADP/ATP translocase 3 | 0 | 0 | 2 | 2 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 0 | 2 | 2 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 2 | 3 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase B-raf | 0 | 0 | 2 | 2 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 0 | 0 | 2 | 2 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase Fer | 0 | 0 | 2 | 2 |
| Protein kinase C alpha type | 0 | 2 | 2 | 5 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 2 | 2 | 4 |
| General transcription and DNA repair factor IIH helicase subunit XPD | 0 | 0 | 2 | 2 |
| Casein kinase II subunit alpha' | 0 | 1 | 2 | 3 |
| Ras-related protein Rab-6A | 0 | 0 | 2 | 2 |
| Ephrin type-A receptor 1 | 0 | 0 | 2 | 2 |
| Multifunctional protein ADE2 | 0 | 0 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit gamma | 0 | 1 | 1 | 2 |
| cAMP-dependent protein kinase catalytic subunit beta | 0 | 1 | 2 | 3 |
| Ferrochelatase, mitochondrial | 0 | 0 | 2 | 2 |
| Ribosomal protein S6 kinase beta-1 | 0 | 1 | 2 | 3 |
| Tyrosine-protein kinase JAK1 | 0 | 0 | 2 | 2 |
| Cyclin-dependent kinase 2 | 0 | 0 | 2 | 2 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 2 | 2 |
| Probable ATP-dependent RNA helicase DDX6 | 0 | 0 | 2 | 2 |
| MAP/microtubule affinity-regulating kinase 3 | 0 | 0 | 2 | 2 |
| Deoxycytidine kinase | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 0 | 2 | 2 |
| Ephrin type-A receptor 2 | 0 | 0 | 2 | 2 |
| Ephrin type-B receptor 2 | 0 | 0 | 2 | 2 |
| Non-receptor tyrosine-protein kinase TYK2 | 0 | 0 | 2 | 2 |
| UMP-CMP kinase | 0 | 0 | 2 | 2 |
| Phosphatidylethanolamine-binding protein 1 | 0 | 0 | 2 | 2 |
| Wee1-like protein kinase | 0 | 0 | 2 | 2 |
| Heme oxygenase 2 | 0 | 0 | 2 | 2 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 2 | 2 |
| DnaJ homolog subfamily A member 1 | 0 | 0 | 2 | 2 |
| RAC-alpha serine/threonine-protein kinase | 0 | 2 | 2 | 4 |
| RAC-beta serine/threonine-protein kinase | 0 | 1 | 2 | 3 |
| Dual specificity protein kinase TTK | 0 | 0 | 2 | 2 |
| DNA replication licensing factor MCM4 | 0 | 0 | 2 | 2 |
| Myosin-10 | 0 | 0 | 2 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 0 | 2 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 0 | 2 | 2 |
| Bone morphogenetic protein receptor type-1A | 0 | 0 | 2 | 2 |
| Activin receptor type-1B | 0 | 0 | 2 | 2 |
| TGF-beta receptor type-1 | 0 | 0 | 2 | 2 |
| TGF-beta receptor type-2 | 0 | 0 | 2 | 2 |
| Electron transfer flavoprotein subunit beta | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase CSK | 0 | 0 | 2 | 2 |
| Glycine--tRNA ligase | 0 | 0 | 2 | 2 |
| Protein kinase C iota type | 0 | 2 | 2 | 5 |
| Exosome RNA helicase MTR4 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase mTOR | 0 | 2 | 2 | 4 |
| Tyrosine-protein kinase Tec | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase ABL2 | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase FRK | 0 | 0 | 2 | 2 |
| G protein-coupled receptor kinase 6 | 0 | 1 | 2 | 3 |
| Tyrosine-protein kinase SYK | 0 | 1 | 2 | 3 |
| 26S proteasome regulatory subunit 6B | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 8 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 9 | 0 | 0 | 2 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 0 | 2 | 2 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0 | 0 | 2 | 2 |
| Casein kinase I isoform alpha | 0 | 1 | 2 | 3 |
| Casein kinase I isoform delta | 0 | 1 | 2 | 3 |
| MAP kinase-activated protein kinase 2 | 0 | 0 | 2 | 2 |
| Elongation factor Tu, mitochondrial | 0 | 0 | 2 | 2 |
| Choline-phosphate cytidylyltransferase A | 0 | 0 | 2 | 2 |
| Cysteine--tRNA ligase, cytoplasmic | 0 | 0 | 2 | 2 |
| Casein kinase I isoform epsilon | 0 | 1 | 2 | 3 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 0 | 0 | 2 | 2 |
| Dual specificity protein kinase CLK1 | 0 | 0 | 2 | 2 |
| Dual specificity protein kinase CLK2 | 0 | 0 | 2 | 2 |
| Dual specificity protein kinase CLK3 | 0 | 0 | 2 | 2 |
| Glycogen synthase kinase-3 alpha | 0 | 0 | 2 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 2 | 3 |
| Cyclin-dependent kinase 7 | 0 | 0 | 2 | 2 |
| Cyclin-dependent kinase 9 | 0 | 0 | 2 | 2 |
| Ras-related protein Rab-27A | 0 | 0 | 2 | 2 |
| Interleukin-1 receptor-associated kinase 1 | 0 | 0 | 2 | 2 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| Ribosomal protein S6 kinase alpha-3 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase Nek2 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase Nek3 | 0 | 0 | 2 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase PLK1 | 0 | 0 | 2 | 2 |
| LIM domain kinase 1 | 0 | 0 | 2 | 2 |
| LIM domain kinase 2 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 10 | 0 | 0 | 2 | 2 |
| Tyrosine--tRNA ligase, cytoplasmic | 0 | 0 | 2 | 2 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 2 |
| Ephrin type-B receptor 3 | 0 | 0 | 2 | 2 |
| Ephrin type-A receptor 5 | 0 | 0 | 2 | 2 |
| Ephrin type-B receptor 4 | 0 | 0 | 2 | 2 |
| Ephrin type-A receptor 4 | 0 | 0 | 2 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 2 | 2 |
| Adenosine kinase | 0 | 0 | 2 | 2 |
| Ras-related protein Rab-10 | 0 | 0 | 2 | 2 |
| Actin-related protein 3 | 0 | 0 | 2 | 2 |
| Actin-related protein 2 | 0 | 0 | 2 | 2 |
| GTP-binding nuclear protein Ran | 0 | 0 | 2 | 2 |
| Casein kinase I isoform gamma-2 | 0 | 1 | 2 | 3 |
| Cyclin-dependent kinase 3 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 6 | 0 | 0 | 2 | 2 |
| Cyclin-dependent-like kinase 5 | 0 | 0 | 2 | 2 |
| Cyclin-dependent kinase 16 | 0 | 0 | 2 | 2 |
| Cyclin-dependent kinase 17 | 0 | 0 | 2 | 2 |
| ATP-dependent 6-phosphofructokinase, platelet type | 0 | 0 | 2 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 0 | 2 | 2 |
| DNA topoisomerase 2-beta | 0 | 0 | 2 | 2 |
| Protein kinase C theta type | 0 | 2 | 2 | 5 |
| Activin receptor type-1 | 0 | 0 | 2 | 2 |
| Macrophage-stimulating protein receptor | 0 | 0 | 2 | 2 |
| Focal adhesion kinase 1 | 0 | 0 | 2 | 2 |
| Protein kinase C delta type | 0 | 2 | 2 | 5 |
| Tyrosine-protein kinase BTK | 0 | 0 | 2 | 2 |
| Activated CDC42 kinase 1 | 0 | 0 | 2 | 2 |
| Epithelial discoidin domain-containing receptor 1 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase 4 | 0 | 0 | 2 | 2 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 5 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 7 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase PAK 2 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase 3 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase 1 | 0 | 0 | 2 | 2 |
| Integrin-linked protein kinase | 0 | 0 | 2 | 2 |
| Rho-associated protein kinase 1 | 0 | 0 | 2 | 2 |
| Non-receptor tyrosine-protein kinase TNK1 | 0 | 0 | 2 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | 0 | 0 | 2 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | 0 | 0 | 2 | 2 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 2 | 2 |
| Activin receptor type-2B | 0 | 0 | 2 | 2 |
| Bone morphogenetic protein receptor type-2 | 0 | 0 | 2 | 2 |
| Protein-tyrosine kinase 6 | 0 | 0 | 2 | 2 |
| cGMP-dependent protein kinase 1 | 0 | 1 | 2 | 3 |
| Cyclin-dependent kinase 13 | 0 | 0 | 2 | 2 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 0 | 2 | 2 |
| Protein-tyrosine kinase 2-beta | 0 | 0 | 2 | 2 |
| Maternal embryonic leucine zipper kinase | 0 | 0 | 2 | 2 |
| Structural maintenance of chromosomes protein 1A | 0 | 0 | 2 | 2 |
| Chromodomain-helicase-DNA-binding protein 4 | 0 | 0 | 2 | 2 |
| Peroxisomal acyl-coenzyme A oxidase 1 | 0 | 0 | 2 | 2 |
| Ephrin type-A receptor 7 | 0 | 0 | 1 | 1 |
| Delta(24)-sterol reductase | 0 | 0 | 2 | 2 |
| Ribosomal protein S6 kinase alpha-1 | 0 | 0 | 2 | 2 |
| Dual specificity testis-specific protein kinase 1 | 0 | 0 | 2 | 2 |
| Myosin light chain kinase, smooth muscle | 0 | 2 | 2 | 4 |
| Mitogen-activated protein kinase 11 | 0 | 1 | 2 | 3 |
| Serine/threonine-protein kinase STK11 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase N1 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase N2 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 2 | 4 |
| Calcium/calmodulin-dependent protein kinase type IV | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase 11 | 0 | 0 | 2 | 2 |
| Discoidin domain-containing receptor 2 | 0 | 0 | 2 | 2 |
| AP2-associated protein kinase 1 | 0 | 0 | 2 | 2 |
| Myosin light chain kinase 3 | 0 | 1 | 2 | 3 |
| Putative heat shock protein HSP 90-beta 2 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase MRCK alpha | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase MRCK gamma | 0 | 0 | 2 | 2 |
| Acyl-CoA dehydrogenase family member 10 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase N3 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase ULK3 | 0 | 0 | 2 | 2 |
| Uncharacterized protein FLJ45252 | 0 | 0 | 2 | 2 |
| Acyl-CoA dehydrogenase family member 11 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase MARK2 | 0 | 0 | 2 | 2 |
| ATP-dependent RNA helicase DHX30 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase TAO1 | 0 | 0 | 2 | 2 |
| STE20-related kinase adapter protein alpha | 0 | 0 | 2 | 2 |
| Myosin-14 | 0 | 0 | 2 | 2 |
| AarF domain-containing protein kinase 1 | 0 | 0 | 2 | 2 |
| ATP-dependent RNA helicase DDX42 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | 0 | 0 | 2 | 2 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | 0 | 0 | 1 | 1 |
| Regulatory-associated protein of mTOR | 0 | 2 | 0 | 2 |
| Atypical kinase COQ8A, mitochondrial | 0 | 0 | 2 | 2 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 15 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase Nek9 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase Nek7 | 0 | 0 | 1 | 1 |
| ATP-dependent RNA helicase DDX1 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | 0 | 0 | 2 | 2 |
| Aurora kinase B | 0 | 0 | 3 | 3 |
| MAP/microtubule affinity-regulating kinase 4 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase Nek1 | 0 | 0 | 2 | 2 |
| PAS domain-containing serine/threonine-protein kinase | 0 | 0 | 2 | 2 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | 0 | 1 | 2 | 3 |
| EKC/KEOPS complex subunit TP53RK | 0 | 0 | 2 | 2 |
| Dual specificity testis-specific protein kinase 2 | 0 | 0 | 2 | 2 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase 5 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase 3 | 0 | 0 | 2 | 2 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | 0 | 0 | 2 | 2 |
| Target of rapamycin complex subunit LST8 | 0 | 2 | 0 | 2 |
| Nucleolar GTP-binding protein 1 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase D2 | 0 | 0 | 2 | 2 |
| NUAK family SNF1-like kinase 2 | 0 | 0 | 1 | 1 |
| RNA cytidine acetyltransferase | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase SIK2 | 0 | 0 | 2 | 2 |
| STE20-like serine/threonine-protein kinase | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase TAO3 | 0 | 0 | 2 | 2 |
| dCTP pyrophosphatase 1 | 0 | 0 | 2 | 2 |
| Dual specificity protein kinase CLK4 | 0 | 0 | 2 | 2 |
| Casein kinase I isoform gamma-1 | 0 | 1 | 2 | 3 |
| Phenylalanine--tRNA ligase beta subunit | 0 | 0 | 2 | 2 |
| BMP-2-inducible protein kinase | 0 | 0 | 2 | 2 |
| Obg-like ATPase 1 | 0 | 0 | 2 | 2 |
| Midasin | 0 | 0 | 2 | 2 |
| Interleukin-1 receptor-associated kinase 4 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase 20 | 0 | 0 | 2 | 2 |
| Cyclin-dependent kinase 12 | 0 | 0 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 26 | 0 | 0 | 2 | 2 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase NLK | 0 | 0 | 2 | 2 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase TBK1 | 0 | 0 | 2 | 2 |
| Septin-9 | 0 | 0 | 2 | 2 |
| Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
| Ribosomal protein S6 kinase alpha-6 | 0 | 0 | 2 | 2 |
| TRAF2 and NCK-interacting protein kinase | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase TAO2 | 0 | 0 | 2 | 2 |
| Long-chain-fatty-acid--CoA ligase 5 | 0 | 0 | 1 | 1 |
| RAC-gamma serine/threonine-protein kinase | 0 | 1 | 2 | 3 |
| Serine/threonine-protein kinase SIK3 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase 2 | 0 | 0 | 2 | 2 |
| Thyroid hormone receptor-associated protein 3 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | 0 | 0 | 2 | 2 |
| Receptor-interacting serine/threonine-protein kinase 3 | 0 | 0 | 2 | 2 |
| Serine/threonine-protein kinase MRCK beta | 0 | 0 | 2 | 2 |
| Interleukin-1 receptor-associated kinase 3 | 0 | 0 | 2 | 2 |
| Casein kinase I isoform gamma-3 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase kinase kinase 4 | 0 | 0 | 2 | 2 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| fructose-bisphosphate aldolase | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Albumin | 0 | 3 | 2 | 5 |
| Serum paraoxonase/arylesterase 1 | 0 | 3 | 0 | 3 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 1 | 3 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 1 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 3 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Pancreatic alpha-amylase | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 2 | 0 | 1 | 1 | 2 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Chain E, C-amp-dependent Protein Kinase | 0 | 1 | 0 | 1 |
| Chain I, Protein Kinase Inhibitor Peptide | 0 | 1 | 0 | 1 |
| Chain E, C-amp-dependent Protein Kinase | 0 | 1 | 0 | 1 |
| Chain E, C-amp-dependent Protein Kinase | 0 | 1 | 0 | 1 |
| Chain I, Protein Kinase Inhibitor Peptide | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | 0 | 2 | 0 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 3 | 0 | 3 |
| Protein kinase C gamma type | 0 | 2 | 0 | 3 |
| cAMP-dependent protein kinase catalytic subunit beta | 0 | 2 | 0 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 1 | 2 |
| Myosin light chain kinase, smooth muscle | 0 | 2 | 0 | 2 |
| Protein kinase C eta type | 0 | 2 | 0 | 3 |
| cAMP-dependent protein kinase type II-beta regulatory subunit | 0 | 2 | 0 | 2 |
| Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 2 | 0 | 3 |
| Protein kinase C zeta type | 0 | 2 | 1 | 4 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase D1 | 0 | 2 | 0 | 3 |
| Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 4 | 0 | 0 | 4 |
| transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 0 | 5 | 2 | 7 |
| Adenosine receptor A1 | 0 | 1 | 1 | 3 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 1 | 4 |
| Histamine H1 receptor | 0 | 1 | 3 | 4 |
| Histamine H1 receptor | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
| Histamine H1 receptor | 0 | 2 | 2 | 4 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 2 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| Delta-type opioid receptor | 0 | 2 | 0 | 3 |
| Delta-type opioid receptor | 0 | 3 | 1 | 5 |
| Mu-type opioid receptor | 0 | 3 | 1 | 7 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 4 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Phospholipase A2, major isoenzyme | 0 | 2 | 0 | 3 |
| Procathepsin L | 0 | 1 | 1 | 2 |
| Interleukin-8 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 5 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
| Caspase-1 | 0 | 0 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
| C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
| Chain A, BETA-SPECTRIN | 0 | 0 | 1 | 1 |
| Chain A, Phospholipase C Delta-1 | 0 | 0 | 1 | 1 |
| Chain A, Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 0 | 1 | 1 |
| Inositol-trisphosphate 3-kinase A | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 0 | 2 | 2 |
| Inositol 1,4,5-trisphosphate receptor type 2 | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 3 | 0 | 1 | 1 | 2 |
| Inositol polyphosphate-5-phosphatase A | 0 | 1 | 0 | 1 |
| Inositol 1,4,5-trisphosphate receptor type 1 | 0 | 1 | 1 | 2 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
| Camphor 5-monooxygenase | 0 | 0 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 3 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Steroid 21-hydroxylase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 5 | 0 | 5 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
| Translocator protein | 0 | 1 | 1 | 2 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 1 | 5 |
| Substance-K receptor | 0 | 6 | 0 | 6 |
| Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 8 | 0 | 8 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 9 | 2 | 12 |
| Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 3 | 1 | 5 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
| Protein kinase C delta type | 0 | 2 | 0 | 2 |
| Protein kinase C epsilon type | 0 | 2 | 0 | 2 |
| Protein kinase C zeta type | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 2 | 0 | 2 |
| Protein kinase C beta type | 0 | 2 | 0 | 2 |
| Protein kinase C eta type | 0 | 2 | 0 | 2 |
| Protein kinase C theta type | 0 | 2 | 0 | 2 |
| Alpha-crystallin B chain | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 2 | 0 | 0 | 2 |
| 14-alpha sterol demethylase | 0 | 0 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 2 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| hypothetical protein, conserved | 3 | 0 | 0 | 3 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 0 | 1 | 1 |
| D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
| 5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 5 | 1 | 6 |
| D | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 1B | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 8 | 1 | 9 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 3D | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
| Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 4 | 0 | 4 |
| Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
| Tegument protein VP16 | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 7 | 2 | 10 |
| Kappa-type opioid receptor | 0 | 7 | 2 | 10 |
| Progesterone receptor | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Histidine decarboxylase | 0 | 0 | 1 | 1 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 1 | 5 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 5 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| Tubulin alpha-1A chain | 0 | 0 | 1 | 2 |
| Tubulin beta chain | 0 | 0 | 1 | 1 |
| Tubulin beta-4A chain | 0 | 1 | 1 | 3 |
| Integrin alpha-V | 0 | 1 | 0 | 1 |
| Tubulin beta chain | 0 | 1 | 1 | 3 |
| Tubulin alpha-3C chain | 0 | 1 | 1 | 3 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 3 | 1 | 4 |
| Melanocortin receptor 5 | 0 | 4 | 0 | 4 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Tubulin alpha-1B chain | 0 | 1 | 1 | 3 |
| Tubulin alpha-4A chain | 0 | 1 | 1 | 3 |
| Tubulin beta-4B chain | 0 | 1 | 1 | 3 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Mer | 0 | 1 | 1 | 2 |
| Tubulin beta-3 chain | 0 | 2 | 1 | 4 |
| Tubulin beta-2A chain | 0 | 1 | 1 | 3 |
| Beta-tubulin | 0 | 1 | 0 | 1 |
| Tubulin beta-8 chain | 0 | 1 | 1 | 3 |
| Tubulin beta-2B chain | 0 | 0 | 1 | 3 |
| Tubulin alpha-3E chain | 0 | 1 | 1 | 3 |
| Tubulin alpha-1A chain | 0 | 1 | 1 | 3 |
| Similar to alpha-tubulin isoform 1 | 0 | 0 | 1 | 3 |
| Similar to alpha-tubulin isoform 1 | 0 | 0 | 0 | 2 |
| Tubulin alpha-1C chain | 0 | 1 | 1 | 3 |
| Tubulin beta-6 chain | 0 | 1 | 1 | 3 |
| Tubulin beta-2B chain | 0 | 1 | 1 | 3 |
| Tubulin beta-1 chain | 0 | 1 | 1 | 3 |
| Nucleotide-binding oligomerization domain-containing protein 2 | 0 | 1 | 0 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| rac GTPase-activating protein 1 isoform a | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
| Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
| D(1A) dopamine receptor | 0 | 3 | 1 | 4 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase JAK2 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase-like 5 | 0 | 0 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Eukaryotic translation initiation factor 4E | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase receptor R3 | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 18 | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Uncharacterized aarF domain-containing protein kinase 5 | 0 | 0 | 1 | 1 |
| Programmed cell death protein 4 | 0 | 0 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | 0 | 0 | 1 | 1 |
| Misshapen-like kinase 1 | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type 1G | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Isoleucine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase ICK | 0 | 0 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 24 | 0 | 0 | 1 | 1 |
| Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 2 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 2 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| Cadherin-1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Adenomatous polyposis coli protein | 0 | 1 | 0 | 1 |
| Catenin beta-1 | 0 | 2 | 0 | 2 |
| Transcription factor 7-like 2 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |